Carlos Augusto Scussel Madalosso

Dr. Carlos Augusto Scussel Madalosso


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Annals of Surgery
Verified
Journal Article
Closed access
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso
RGRichard Ricachenevsky Gurski
Richard Ricachenevsky Gurski
SCSidia M. Callegari-Jacques
Sidia M. Callegari-Jacques
DNDaniel Navarini
Daniel Navarini
GMGuilherme Mazzini
Guilherme Mazzini
MPMarina da Silva Pereira
Marina da Silva Pereira
To assess the impact of Roux-en-Y gastric bypass (GBP) on gastroesophageal reflux disease (GERD) in morbidly obese patients. Recently, authors have reported that early results of GBP can control GERD. However, longer follow-ups based on objective parameters for GERD are missing. Fifty-three patients [15 men (28%), 39 years old (range, 18-59), body mass index = 46 ± 7.7 kg/m2] were consecutively evaluated for GERD irrespectively of related symptoms, before the operation (E1) and at 6 (E2) and 39 ± 7 months postoperatively (E3). The end points were (1) esophageal syndromes based on the Montreal Consensus and (2) an esophageal acid exposure assessment. Body mass index dropped from 46 ± 7.7 kg/m2 at E1 to 30 ± 5.2 kg/m2 at E3. Typical reflux syndrome displayed a significant decrease from 31 (58%) at E1 to 8 (15%) at E2 and 5 (9%) at E3. Statistically significant differences occurred between E1 and both postoperative evaluations (P < 0.001). Reflux esophagitis was detected in 24 (45%), 17 (32%), and 10 patients (19%) at E1, E2, and E3, respectively (P = 0.002). The incidence of GERD decreased in 34 (64%) and 21 (40%) patients at E1 and E2, respectively, and then in 12 (23%) patients at E3. DeMeester scores reduced from 28.6 (E1) to 9.4 (E2) and 1.2 (E3) (P < 0.001). For most morbidly obese patients, in addition to causing significant weight loss, GBP reduces GERD symptoms, improves reflux esophagitis, and decreases esophageal acid exposure for longer than 3 years.

1 August 1998 in Transplantation
Verified
Journal Article
Closed access
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso
NSNelson F. de Souza
Nelson F. de Souza
DIDuane M. Ilstrup
Duane M. Ilstrup
RWRussell H. Wiesner
Russell H. Wiesner
RKRuud A.F. Krom
Ruud A.F. Krom
Hepatic artery thrombosis (HAT) is a cause of morbidity and graft loss in approximately 7% of patients after an orthotopic liver transplantation (OLT). Although technical problems are often thought to be the cause of HAT, in general the etiology remains unclear. Because cytomegalovirus (CMV) can infect endothelial cells in vitro and lead to a rapid procoagulant response, it can be hypothesized that, in the absence of CMV antibodies, latent CMV in an allograft may become activated and promote or contribute to vascular thrombosis. Therefore, the purpose of this study was to examine the relationship between CMV serology of the donor and recipient with the development of HAT after OLT. Between July 1988 and November 1995 (University of Wisconsin era), 490 OLTs were performed in 413 patients. Subsequently, four patients were excluded in whom the CMV serology results of the donor were not available. Sixteen of the 409 patients developed HAT within 30 days after liver transplantation. The control group consisted of the other 393 patients. The incidence of HAT was 12.5% in 64 CMV D+R- patients and 0% in 52 CMV D-R- patients. However, in the other combinations (D+R+ and D-R+), the incidence was only 2.8% (P=0.005). Eight of the 16 patients with HAT belonged to the CMV D+R- group. We conclude that CMV-seronegative patients receiving a seropositive allograft may be at risk for early HAT. Seropositivity of the donor alone and of the recipient alone was not significantly related to the incidence of HAT. Prophylactic treatment with ganciclovir and/or anticoagulation should be evaluated to prevent this complication.

1 February 2010 in Annals of Surgery
Verified
Journal Article
Closed access
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso
RGRichard R. Gurski
Richard R. Gurski
SCSidia M. Callegari-Jacques
Sidia M. Callegari-Jacques
DNDaniel Navarini
Daniel Navarini
VTVictor Thiesen
Victor Thiesen
FFFernando Fornari
Fernando Fornari
To assess the impact of gastric bypass (GBP) on gastroesophageal reflux disease (GERD) based on Montreal Consensus. In this study, 86 patients (25 men; aging 38 +/- 12 years; body mass index 45 [35-68 kg/m2]) were investigated for GERD before GBP and 6 months later. Esophageal and extraesophageal syndromes were assessed based on Montreal Consensus. Esophageal acid exposure and gastric pouch acidity were also evaluated. Overall prevalence of GERD was 64% before GBP and 33% after GBP (P < 0.0001). Typical reflux syndrome (TRS) was present in 47 patients (55%) preoperatively and disappeared in 39 of them (79%) post-GBP. Out of 39 patients with no symptoms, 4 (10%) developed TRS postoperatively (P < 0.0001). The chief TRS complaint changed from heartburn pre-GBP (96%) to regurgitation post-GBP (64%). Esophageal mucosa improved in 27, was unchanged in 51, and worsened in 8 patients (P = 0.001) in regard of esophagitis. Extraesophageal syndromes were present in 16 patients preoperatively and in none but one post-GBP (P = 0.0003). GERD-related well being and use of proton pump inhibitors were both improved after GBP. Total acid exposure decreased from a median (interquartile range, 25%-75%) of 5.1% (range, 2-8.2) to 1.1% (range, 0.2-4.8), P = 0.0002. Most patients (86%) showed and acid gastric pouch in fasting conditions post-GBP. GBP ameliorated GERD syndromes in most patients 6 months after the procedure, resulting in quality of life improvement and less proton pump inhibitors usage. Whether regurgitation post-GBP corresponds to reflux disease or bad eating behavior deserves further studies.

6 February 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
DNDaniel Navarini
Daniel Navarini
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso
ATAlexandre P. Tognon
Alexandre P. Tognon
FFFernando Fornari
Fernando Fornari
FBFábio R. Barão
Fábio R. Barão
RGRichard R. Gurski
Richard R. Gurski

12 September 2009 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
FFFernando Fornari
Fernando Fornari
RGRichard Ricachenevsky Gurski
Richard Ricachenevsky Gurski
DNDaniel Navarini
Daniel Navarini
VTVictor Thiesen
Victor Thiesen
LMLuis Henrique Barbosa Mestriner
Luis Henrique Barbosa Mestriner
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso

1 April 2010 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
FFFernando Fornari
Fernando Fornari
CMCarlos Augusto Scussel Madalosso
Carlos Augusto Scussel Madalosso
RFRicard Farre
Ricard Farre
RGRichard R. Gurski
Richard R. Gurski
VTVictor Thiesen
Victor Thiesen
SCSidia M. Callegari-Jacques
Sidia M. Callegari-Jacques
The relationship between gastro-oesophageal pressure gradient (GOPG), sliding hiatal hernia (SHH) and gastro-oesophageal reflux disease (GORD) is under investigation. We assessed whether GOPG and SHH are predictors of pathological reflux in severely obese patients.Ninety-four consecutive patients were prospectively studied with oesophageal manometry, 24-h pH monitoring, upper gastrointestinal endoscopy and barium swallow X-ray. Inspiratory and expiratory GOPGs were measured at manometry testing, whereas SHH was characterized by X-ray. Patients were classified as having physiological or pathological reflux depending on pH monitoring. Patients with oesophagitis but normal pH testing were excluded.Eighty-nine patients composed the study sample (25 men, 38.3+/-11.1 years; BMI 45+/-6.9 kg/m). Sixty-two patients (70%) had pathological reflux, whereas 27 patients (30%) had physiological reflux. Pathological reflux was predicted either by inspiratory GOPG [prevalence ratio (PR) =1.05; 95% confidence interval (CI): 1.03-1.08; P<0.001] or by expiratory GOPG (PR=1.07; 95% CI: 1.03-1.11; P=0.001). Accordingly, an increment of 1 mmHg in inspiratory and expiratory GOPGs raises the risk of pathological reflux in 5 and 7%, respectively. Pathological reflux was also predicted by SHH (PR: 1.54, 95% CI: 1.19-2.00; P=0.001), which increases the risk of abnormal reflux in 54%.In severely obese patients, either inspiratory GOPG, expiratory GOPG or SHH are predictors of pathological reflux. These findings give pathophysiological support to the high prevalence of GORD in this population.